Doris Barcellona/Fondazione Arianna Anticoagulazione
Aug 22, 2025, 03:37
Lupus Anticoagulant-Hypoprothrombinemia Syndrome: Review by Doris Barcellona and Colleagues
Maria Filomena Ruberto, Biologist specialized in Clinical Pathology and Clinical Biochemistry and II Level Master’s degree in Hemostasis and Thrombosis, shared on LinkedIn:
”Doris Barcellona et al.Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient. Semin Thromb Hemost. 2025.”
Read the full article here.
Article: Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient
Authors: Doris Barcellona , Antonella Mameli , Roberta Montisci , Maria Filomena Ruberto , Lara Fenu , Francesco Marongiu
Stay updated on all scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Apr 12, 2026, 11:36Ifeanyichukwu Ifechidere: From Running Tests to Trusting Interpretation in Coagulation
-
Apr 12, 2026, 11:30Zack Rosanova: What Happens to Your Brain Without Sleep
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine